La cadena de opciones muestra datos clave de las opciones de acciones de Marketwise a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Marketwise..

Marketwise (NASDAQ:MKTW) Bolsa, Cadena de Opciones

Marketwise

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

Marketwise Inc

News

Trump's 'Big Beautiful Bill' To Inject $150 Billion Into Immigration Enforcement Over The Next Four Years: Report

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) CEO Andy Jassy&#8216;s recent announcement that artificial intelligence will shrink the company&#8217;s corporate workforce has prompted a stark warning from former Amazon Vice President Ethan Evans, who says employees must adapt or face elimination.
Check out the current price of <a href="https://benzinga.com/quote/amzn">AMZN stock here</a>.
What Happened: Evans wrote on X on Wednesday that Jassy is delivering &#8220;a really simple truth&#8221; to give current Amazon employees time to prepare for job competition driven by AI efficiency gains. &#8220;Amazon, even with new projects, does not expect to keep everyone,&#8221; Evans stated, adding that the company will retain &#8220;the most productive, most valuable people.&#8221;
The former VP, who worked directly with Jassy, characterized the CEO&#8217;s Tuesday blog post as firing &#8220;the starting gun&#8221; on an internal race where employees must prove their AI-resistant value or risk layoffs.
Evans urged workers to identify skills that AI cannot easily replace and invest in capabilities where AI enhances rather than replaces human performance.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Andy Jassy is trying to lay out a really simple truth soon enough to give everyone currently at Amazon a chance to adapt: 1) Amazon, even with new projects, does not expect to keep everyone 2) They are going to keep the best (most productive, most valuable) people 3) Yes,…
&mdash; Ethan Evans (@EthanEvansVP) <a href="https://twitter.com/EthanEvansVP/status/1937970794984051125?ref_src=twsrc%5Etfw">June 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/46107638/mark-zuckerbergs-meta-beats-lawsuit-over-ai-training-on-books-judge-finds-no-meaningful-evidence-on-market-dilution">Mark Zuckerberg&#8217;s Meta Beats Lawsuit Over AI Training On Books, Judge Finds &#8216;No Meaningful Evidence On Market Dilution&#8217;</a>
Why It Matters: Jassy&#8217;s announcement last week revealed <a href="https://www.benzinga.com/markets/tech/25/06/45990634/amazon-ceo-andy-jassys-ai-led-job-cuts-warning-sparks-backlash-as-employee-reportedly-says-its-clearly-part-of-the-plan">Amazon has over 1,000 generative AI services</a> and applications in development. The company&#8217;s AI-driven Alexa+ serves tens of millions of customers globally, while more than 50,000 advertisers used AI capabilities in the first quarter alone. 
Amazon has committed over $100 billion to <a href="https://www.benzinga.com/markets/tech/25/06/45990634/amazon-ceo-andy-jassys-ai-led-job-cuts-warning-sparks-backlash-as-employee-reportedly-says-its-clearly-part-of-the-plan">AI infrastructure investments</a>, including $13 billion for Australia&#8217;s data center expansion through 2029.
Internal employee reactions viewed by Business Insider <a href="https://www.benzinga.com/markets/tech/25/06/45990634/amazon-ceo-andy-jassys-ai-led-job-cuts-warning-sparks-backlash-as-employee-reportedly-says-its-clearly-part-of-the-plan">showed mixed responses across Slack channels</a>. &#8220;There is nothing more motivating on a Tuesday than reading that your job will be replaced by AI in a few years,&#8221; one employee wrote. Others questioned whether senior leadership would face similar cuts, noting Amazon&#8217;s S-team expansion under Jassy.
The workforce warning comes as Amazon froze <a href="https://www.benzinga.com/markets/tech/25/06/45990634/amazon-ceo-andy-jassys-ai-led-job-cuts-warning-sparks-backlash-as-employee-reportedly-says-its-clearly-part-of-the-plan">retail hiring budgets this year</a> while expanding AI capabilities. Jassy previously called AI investments a &#8220;once-in-a-lifetime reinvention of everything we know,&#8221; emphasizing substantial capital requirements for AI chips and data centers.
Evans warned that attacking leadership for delivering &#8220;unpleasant truth&#8221; only encourages delays that lead to &#8220;brutal surprise down the road.&#8221; He advised employees to start transitioning skills immediately, stating, &#8220;Get started or get hurt.&#8221;
AMZN performs strongly on Growth and Quality metrics, with decent Momentum and Value scores. For&nbsp;<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">more insights like this, subscribe</a>&nbsp;to&nbsp;Benzinga Edge Stock Rankings&nbsp;today! <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener"></a>
<figure class="wp-block-image aligncenter size-full is-resized"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="886" height="638" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042940/image-402.png" alt="" class="wp-image-962820" style="width:416px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042940/image-402.png 886w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042940/image-402-300x216.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042940/image-402-768x553.png 768w" sizes="(max-width: 886px) 100vw, 886px" /></a></figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46109638/microsoft-ceo-satya-nadella-praises-palantirs-fde-model-as-fantastic-insiders-say-its-not-consulting-it-builds-the-product-customers-need">Microsoft CEO Satya Nadella Praises Palantir&#8217;s FDE Model As &#8216;Fantastic&#8217;—Insiders Say It&#8217;s Not Consulting, It Builds &#8216;The Product Customers Need&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Markus Mainka / Shutterstock.com

Equities

Markets

AMZN

Amazon CEO Andy Jassy Warns Of AI-Driven Workforce Reduction — AMZN 'Won't Keep Everyone,' Says Ex-VP Ethan Evans In Warning To Employees

Patrick&nbsp;Witt, deputy director of the White House Council on Digital Assets, said Wednesday that the administration is pursuing a &#8220;accumulation plan&#8221; to acquire Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) for the strategic national reserve.
What Happened:&nbsp;During a fireside chat at the Bitcoin Policy Summit in Washington, D.C., Witt emphasized the Trump administration&#8217;s dedication to the leading cryptocurrency.
&#8220;We&#8217;ve&nbsp;already taken some steps with&nbsp;the SBR [Strategic Bitcoin Reserve]. How&nbsp;do we follow that up&nbsp;with an accumulation plan,&#8221; he stated. &#8220;There&#8217;s no shortage of opportunities and things to do.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The Bitcoin Policy Summit 2025" width="500" height="281" src="https://www.youtube.com/embed/nog5yD9fVhE?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Witt also acknowledged the challenges in implementing these plans, but assured that the team is &#8220;working around the clock&#8221; to realize President Donald Trump&#8217;s vision.
&#8220;The&nbsp;president on down we&#8217;re&nbsp;all committed to Bitcoin. We&nbsp;want to see it thrive.&nbsp;We want this to be&nbsp;the crypto capital of the&nbsp;world,&#8221; he said.
See Also:&nbsp;<a href="https://benzinga.com/crypto/cryptocurrency/25/06/45995223/genius-stablecoin-bill-clears-senate-but-trumps-crypto-profits-loom-over-momentum" target="_blank" rel="noreferrer noopener">GENIUS Stablecoin Bill Clears Senate But Trump's Crypto Profits Loom Over Momentum</a>
Why It Matters:&nbsp;Witt&#8217;s remarks aligned with previous indications from the White House regarding its focus on Bitcoin. In March, Bo Hines, the&nbsp;executive director of the White House Council on Digital Assets, <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44450232/white-house-says-gold-reserves-may-be-used-to-purchase-bitcoin">hinted at the possibility</a> of the U.S. utilizing its gold reserves to acquire more Bitcoin.
Last month, Trump's crypto and AI advisor, David Sacks, said that the path to acquiring Bitcoin for the strategic reserve is ready and it's just a matter of <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45635887/trumps-crypto-advisor-about-us-plans-on-buying-more-bitcoin-it-all-boils-down-to">getting the relevant executive departments "excited</a>." 
Trump signed an executive order to&nbsp;<a href="https://www.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise" target="_blank" rel="noreferrer noopener">establish</a>&nbsp;a strategic Bitcoin reserve earlier this year. The order allows for the purchase of additional BTC, provided there are no incremental costs to taxpayers.
However, little has come from the executive side since the order was signed. Moreover, some analysts have dubbed the idea of selling gold to accumulate Bitcoin&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44148667/a-benzinga-debate-on-federal-reserve-assets-our-contributors-speak-on-gold-bitcoin" target="_blank" rel="noreferrer noopener">a &#8220;very risky&#8221; prospect</a>.
Price Action:&nbsp; At the time of writing, Bitcoin was exchanging hands at $107,813.32, up 1.08% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/25/06/46109437/anthony-pomplianos-company-may-have-bought-more-bitcoin-than-gamestop-but-michael-saylors-strategy-and-mara-still-reign-supreme">Anthony Pompliano&#8217;s Company May Have Bought More Bitcoin Than GameStop, But Michael Saylor&#8217;s Strategy And MARA Still Reign Supreme</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo: Shutterstock<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

$BTC

White House Official Says Trump Administration Is Committed To Bitcoin, Hints At 'Accumulation Plan' For Strategic Reserve

Shares of Worthington Steel, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) rose sharply in today's pre-market trading as the company reported <a href="https://www.benzinga.com/quote/WS/earnings">stronger-than-expected financial results for the fourth quarter.</a>
The company reported quarterly earnings of $1.05 per share, which beat the analyst consensus estimate of 82 cents per share.
Worthington Steel shares jumped 15.7% to $30.38 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Vor Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) surged 105.6% to $1.14 in pre-market trading. Vor Bio and RemeGen signed a global license agreement for autoimmune asset Telitacicept, securing $125 million payment and $175 million private placement.</li>
<li>Adial Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) gained 51.2% to $0.3719 in pre-market trading. Adial Pharmaceuticals shares gained 7% on Wednesday after the company announced it secured AD04 production agreements with Cambrex and Thermo Fisher Scientific ahead of its New Drug Application submission to the FDA for the treatment of Alcohol Use Disorder.</li>
<li>MKDWELL Tech Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) gained 30% to $0.3061 in pre-market trading.</li>
<li>Baird Medical Investment Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) rose 17.5% to $7.80 in pre-market trading after gaining 4% on Wednesday.</li>
<li>KWESST Micro Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWE#NASDAQ">KWE</a>) jumped 17.4% to $8.50 in pre-market trading after falling 17% on Wednesday.</li>
<li>Beeline Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNE#NASDAQ">BLNE</a>) climbed 16.6% to $1.54 in pre-market trading after falling 7% on Wednesday.</li>
<li>Nano Labs Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) gained 14.2% to $12.95 in pre-market trading after dipping 24% on Wednesday.</li>
<li>Altimmune, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) rose 12.8% to $8.70 in pre-market trading. Altimmune will announce 24-week data from IMPACT Phase 2b trial of Pemvidutide in MASH treatment on June 26.</li>
<li>MillerKnoll, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) gained 10.7% to $19.50 in pre-market trading after the company reported better-than-expected quarterly EPS and sales.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) shares tumbled 30.2% to $0.5310 in pre-market trading after the company announced a proposed public offering.</li>
<li>Globavend Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) dipped 12.2% to $0.6105 in pre-market trading after dipping 44% on Wednesday.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) fell 10.7% to $0.6335 in pre-market trading. ZyVersa Therapeutics, on Wednesday, announced a share purchase agreement for up to $10 million in partnership with Williamsburg Venture Holdings to fund clinical development of Cholesterol Efflux Mediator&#x2122; VAR 200.</li>
<li>GlucoTrack, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) dipped 9.4% to $7.10 in pre-market trading. Glucotrack shares jumped 26% on Wednesday after the company and OneTwo Analytics presented final results of their first-in-human study for a continuous blood glucose monitor, which met all primary and secondary endpoints.</li>
<li>Wag! Group Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) declined 9% to $0.0975 in pre-market trading after gaining 6% on Wednesday.</li>
<li>XCF Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAFX#NASDAQ">SAFX</a>) fell 8.8% to $2.07 in pre-market trading after surging more than 32% on Wednesday.</li>
<li>Portage Biotech Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) declined 7.5% to $5.65 in pre-market trading. Portage Biotech shares gained 7% on Wednesday after the company announced it regained Nasdaq compliance.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) fell 7% to $39.38 in pre-market trading after the company priced its public offering of common stock.</li>
<li>Crescent Biopharma, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBIO#NASDAQ">CBIO</a>) shares fell 6.2% to $16.89 in pre-market trading. Stifel, on Wednesday, initiated coverage on the stock with a Buy rating and announced a price target of $28.</li>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) fell 5% to $0.5992 in pre-market trading after dipping around 32% on Wednesday.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

ADIL

BDMD

BLNE

CBIO

GCTK

KTOS

MKDW

MLKN

ORIS

PRTG

RVPH

SAFX

ZVSA

Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

A widely watched labor market sentiment indicator has dropped to its lowest level since early 2017, excluding the pandemic spike, signaling potential trouble ahead for the U.S. job market.
What Happened: On Wednesday, The Kobeissi Letter shared the results of the recent Conference Board's Consumer Confidence survey, showing that the gap between the percentage of Americans who say jobs are &#8220;plentiful&#8221; and those who say they are &#8220;hard to get&#8221; has shrunk to just 11.1%.
Seen by many economists as a forward-looking signal for labor market strength or weakness, historically, the narrowing of this spread has almost always been followed by a rise in unemployment. The spread is now at its lowest level since 2017, ignoring the spike seen during the COVID-19 pandemic.
See Also: <a href="https://www.benzinga.com/markets/25/06/46013949/people-are-confused-if-houses-arent-selling-why-arent-prices-dropping-thats-insane-one-buyer-says">People Are Confused—If Houses Aren&#8217;t Selling, Why Aren&#8217;t Prices Dropping? &#8216;That&#8217;s Insane,&#8217; One Buyer Says</a>
According to the post, &#8220;It now suggests the unemployment rate could rise to 6.0% in the coming months.&#8221;
For context, the current U.S. unemployment numbers stand at 4.2%, according to <a href="https://www.benzinga.com/25/05/45661563/one-in-four-americans-are-functionally-jobless-the-true-unemployment-metric-thats-raced-to-its-highest-in-months">the latest data</a> from the Bureau of Labor Statistics. As such, these figures show that the labor market is deteriorating faster than the headlines numbers might indicate.
&#8220;The labor market is clearly losing momentum,&#8221; the post says in conclusion.
<figure class="wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A leading indicator in the US job market suggests higher unemployment rates are ahead: The gap between those saying jobs are "plentiful" and "hard to get" declined to 11.1%, the lowest since early 2017, excluding the pandemic spike. In other words, US consumers&#39; perceptions of… <a href="https://t.co/9cB0aU4fFE">pic.twitter.com/9cB0aU4fFE</a>
&mdash; The Kobeissi Letter (@KobeissiLetter) <a href="https://twitter.com/KobeissiLetter/status/1937887003020034351?ref_src=twsrc%5Etfw">June 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: While the U.S. unemployment report came in steady at 4.2% in May, there are growing concerns that AI is <a href="https://www.benzinga.com/tech/25/05/45613320/ai-is-gutting-entry-level-jobs-and-gen-z-is-paying-the-price-warns-linkedins-aneesh-raman">gutting entry-level jobs</a>, hitting recent Gen Z college graduates the hardest.
On Wednesday, economist Craig Shapiro warned that AI <a href="https://www.benzinga.com/markets/economic-data/25/06/46093421/ai-will-disrupt-25-of-us-jobs-by-2030-and-the-fed-cant-save-them-economist-warns">will disrupt 25% of all jobs</a> by 2030, and there is little to nothing that the Federal Reserve can do to address this issue.
&#8220;AI-driven labor displacement, accelerating in 2025, poses a structural crisis that Federal Reserve rate cuts cannot fix,&#8221; he said.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/06/46087650/feds-schmid-says-wait-and-see-approach-right-for-rate-policy-as-tariff-fallout-still-unclear">Fed&#8217;s Schmid Says &#8216;Wait-and-See&#8217; Approach Right For Rate Policy As Tariff Fallout Still Unclear</a></li>
</ul>
Photo courtesy: Shutterstock

Economics

US Labor Market Is Flashing Red: 'Plentiful' Versus 'Hard-To-Get' Job Gauge Hits 4-Year Low, Signals Unemployment Could Jump To 6%

IPOs

Julong Holding Limited Prices Initial Public Offering1.25M Class A Common Shares At $4 Per Share, Totaling $5M; Shares To Start Trading On Nasdaq Under "JLHL"

In a move to help companies deal with mounting volatility in the world economy, C.H. Robinson, a global logistics provider managing 37 million shipments annually, is opening its industry-leading Item-level Solutions to all its customers.
Item-level Solutions provide end-to-end visibility and control across inventories and supply chains at the most granular level—by the individual item or SKU. This includes tracking items in motion or at rest, managing orders and inventory with unparalleled precision, and enabling real-time insights for better planning, cost control, and customer service while reducing blind spots. Using C.H. Robinson's Item-level Solutions, users have seen up to 10-30% percent savings in supply-chain-related expenses.
The initiative bundles C.H. Robinson's advanced analytics, tailored solutions, scale and 120 years of hands-on expertise—a unique combination that no other logistics provider in the marketplace can offer. So far, the fully integrated suite with all its competitive advantages has been used predominantly by shippers with the most complex supply chain needs. Now, Robinson is scaling it up to the rest of its global customer base.
The growing need for item-level control in logistics is spurred by continued disruptions since the pandemic. Volumes handled with C.H. Robinson's newest item-level digital purchase order management tools increased almost twenty-fold between 2023 and 2024, and are on track to double again this year. The company also saw a 300% rise in supply chain design projects using item-level data in the last three years.

CHRW

C.H. Robinson Expands Item-Level Solutions to Help Companies Navigate Supply Chain Challenges

Golar LNG Limited (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLNG#NASDAQ">GLNG</a>) announces today the pricing of $500 million aggregate principal amount of its 2.75% Convertible Senior Notes due 2030 (the "Notes"), in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company has also granted the initial purchasers of the Notes a 30-day option to purchase up to an additional $75 million aggregate principal amount of the Notes in connection with the offering. The offering is expected to close on June 30, 2025, subject to the satisfaction of certain customary closing conditions.
The Notes will be senior, unsecured obligations of the Company, bear interest at a rate of 2.75% per annum, payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2025, mature on December 15, 2030, and be convertible into the Company's common shares, cash, or a combination of shares and cash, at the Company's election. The conversion rate for the Notes will initially equal 17.3834 common shares per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $57.53 per common share, representing an initial conversion premium of approximately 40% over the volume-weighted average price of the Company's common shares of $41.09 on June 25, 2025 and is subject to adjustment upon the occurrence of certain events.
The Notes will be redeemable, in whole or in part (subject to certain limitations), at our option at any time, and from time to time, on or after December 20, 2028 if the last reported sale price of our common shares has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.
If we undergo a fundamental change (as defined in the indenture governing the Notes), holders may require us to purchase the Notes in whole or in part for cash at a fundamental change purchase price equal to 100% of the principal amount of the Notes to be purchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change purchase date.
The Company will use the net proceeds from the sale of the Notes (including any notes sold pursuant to the initial purchasers' option to purchase addition Notes, if exercised) to repurchase 2.5 million of the Company's common shares in connection with the offering of the Notes and for general corporate purposes, which may include, among other things, future growth investments including a contemplated fourth FLNG unit, MKII FLNG conversion costs, FLNG Hilli redeployment costs, repaying indebtedness, and funding working capital and capital expenditures.

Offerings

Buybacks

GLNG

Golar LNG Prices $500M Convertible Senior Notes Offering to Fund Share Buybacks and Future Growth

Future Fund LLC's managing director, Gary Black, thinks that investors should stop focusing on Tesla Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Robotaxi's autonomous driving when compared to Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Waymo when it comes to valuation.
What Happened: In response to a social media reply on X questioning Robotaxi's autonomy, investor Gary Black said Wednesday that &#8220;investors need to stop focusing on Tesla vs. Waymo efficacy.&#8221;
He then added that Waymo had recently conducted an equity raise at a "$45 billion valuation." The investor then shared how Robotaxi's perceived value, with the assumption that Tesla&#8217;s stock value is "60x P/E (vs 25-30% long-term growth) is $500B."
Black said that investors are valuing Robotaxi because of Elon Musk's EV giant's "far greater scalability and profitability." Musk has shared on multiple occasions that most Tesla vehicles can serve as Robotaxis thanks to FSD or Full Self-Driving.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Investors need to stop focusing on <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> vs Waymo efficacy. Waymo recently did an equity raise at $45B valuation. The implied value of Robotaxi assuming the rest of TSLA is valued at 60x P/E (vs 25-30% long-term growth) is $500B. The market is putting a multiple of value on TSLA… <a href="https://t.co/Q10DHCPqmh">https://t.co/Q10DHCPqmh</a>
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1937902585349906457?ref_src=twsrc%5Etfw">June 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The comments come in as the investor had earlier called out a <a href="https://www.benzinga.com/markets/tech/25/06/46088826/gary-black-calls-out-lack-of-constructive-feedback-on-teslas-robotaxi-launch">‘lack of constructive feedback'</a> for the company's Austin launch. Black also rubbished claims of Tesla's Robotaxi being years ahead of competitors as "nonsense."
Tesla's Robotaxi launch in Austin on Sunday has garnered a lot of attention within the auto industry, with experts like Wedbush Securities' Dan Ives praising the launch as a <a href="https://www.benzinga.com/markets/tech/25/06/46049232/dan-ives-hails-very-impressive-robotaxi-ride-in-austin-predicts-55-upside-for-tesla-stock-as-golden-age-begins">golden age for Tesla</a> and Alex Potter, an analyst with investment firm Piper Sandler, said that the launch could <a href="https://www.benzinga.com/markets/tech/25/06/46108079/tslas-robotaxi-could-disrupt-auto-industry-says-piper-sandler-contrasts-goldmans-cautious-view-tesla-will-likely-win" target="_blank" rel="noopener">disrupt</a><a href="https://www.benzinga.com/markets/tech/25/06/46108079/tslas-robotaxi-could-disrupt-auto-industry-says-piper-sandler-contrasts-goldmans-cautious-view-tesla-will-likely-win"> the industry</a>. 
However, the launch has also invited a lot of scrutiny, with NHTSA saying it&#8217;s reviewing incidents where the Robotaxis committed <a href="https://www.benzinga.com/markets/tech/25/06/46067027/tesla-robotaxi-faces-nhtsa-scrutiny-over-traffic-violations-during-austin-launch">possible traffic violations</a> like speeding as well as driving in the wrong lane.
The EV giant also faces a <a href="https://www.benzinga.com/markets/tech/25/06/46068107/elon-musks-tesla-faces-wrongful-death-lawsuit-over-model-s-crash-which-claimed-3-lives-plaintiffs-call-cars-design-defective-and-unreasonably-dangerous">wrongful death lawsuit</a> over a 2024 crash in New Jersey when a Tesla Model S carrying 3 passengers veered off the road, adding to questions over the FSD technology&#8217;s readiness to be deployed into the real world.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="203" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042829/TSLA-JUN-26-2025-1-1024x203.jpg" alt="" class="wp-image-962815" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042829/TSLA-JUN-26-2025-1-1024x203.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042829/TSLA-JUN-26-2025-1-300x59.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042829/TSLA-JUN-26-2025-1-768x152.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042829/TSLA-JUN-26-2025-1-1536x304.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26042829/TSLA-JUN-26-2025-1.jpg 1561w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Tesla scores well on Momentum, Quality and Growth metrics, but offers poor Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46087914/teslas-europe-sales-slide-for-5th-straight-month-elon-musk-led-ev-giants-market-share-shrinks-to-1-3">Tesla&#8217;s Europe Sales Slide For 5th Straight Month: Elon Musk-led EV Giant&#8217;s Market Share Shrinks To 1.3%</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

GOOG

GOOGL

TSLA

Gary Black Weighs In On Tesla Vs Waymo Debate, Says Investors Need To Stop Focusing On Efficacy

Billionaire David Tepper&#8216;s hedge fund Appaloosa Management L.P. made significant changes to its portfolio in the first quarter of 2025 as it reduced its holding in the Jensen Huang-led tech giant Nvidia Corp.
What Happened: The hedge fund made crucial changes in its holdings during the quarter that ended March 31, 2025 according to its 13F filings.
This included offloading 56% of its stake in Nvidia, reducing the value of its holdings to $32.514 million at the end of the first quarter.
Meanwhile, the firm completely exited its competitor Advanced Micro Devices Inc., offloading all of its 1.2 million shares in the company.
It also added two new key positions in the first quarter, which included an addition of 75,000 shares of Jack Dorsey&#8216;s Block Inc. valued at $4.074 million and 130,000 shares of Broadcom Inc. valued at $21.765 million.
When looking at other Magnificent 7 stocks in its portfolio, the fund held no common stocks of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
However, Appaloosa offloaded shares of Microsoft Corp. and Amazon.com Inc. during the said quarter, and added Alphabet Inc. and Meta Platforms Inc. to its portfolio.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Company</td>
<td>Holdings (as of Dec. 31)</td>
<td>Holdings (as of March 31)</td>
<td>Change (in %)</td>
<td>Value (as of March 31)</td>
</tr>
<tr>
<td>Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</td>
<td>680,001</td>
<td>300,000</td>
<td>-56%</td>
<td>$32.514 million</td>
</tr>
<tr>
<td>Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)</td>
<td>1,200,000</td>
<td>0</td>
<td>-100%</td>
<td>0</td>
</tr>
<tr>
<td>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)</td>
<td>0</td>
<td>130,000</td>
<td>New</td>
<td>$21.765 million</td>
</tr>
<tr>
<td>Block Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>)</td>
<td>0</td>
<td>75,000</td>
<td>New</td>
<td>$4.074 million</td>
</tr>
<tr>
<td>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</td>
<td>970,000</td>
<td>510,000</td>
<td>-47%</td>
<td>$191.448 million</td>
</tr>
<tr>
<td>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>2,600,000</td>
<td>2,510,000</td>
<td>-3%</td>
<td>$477.552 million</td>
</tr>
<tr>
<td>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)</td>
<td>1,881,963</td>
<td>2,010,000</td>
<td>7%</td>
<td>$314.022 million</td>
</tr>
<tr>
<td>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</td>
<td>490,000</td>
<td>550,000</td>
<td>12%</td>
<td>$316.998 million</td>
</tr>
</tbody>
</table>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/06/46068345/blackrock-bets-big-on-defense-companies-amid-escalating-geopolitical-tensions-palantir-lockheed-martin-northrop-grumman-among-stocks-in-focus" target="_blank" rel="noreferrer noopener">BlackRock Bets Big On Defense Companies Amid Escalating Geopolitical Tensions: Palantir, Lockheed Martin, Northrop Grumman Among Stocks In Focus</a>
Why It Matters: As the Magnificent 7 stocks have an exposure to artificial intelligence (AI) and weigh the heaviest in the S&amp;P 500 index, Appaloosa&#8217;s move to reduce its holdings raises questions about the fund&#8217;s plans.
However, Block and Broadcom do add exposure to blockchain and AI in Appaloosa&#8217;s portfolio, a fund known for specializing in distressed debt.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose on Wednesday. The SPY was up 0.056% at $607.12, while the QQQ rose 0.26% to $541.16, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Thursday, the futures of the S&amp;P 500, Dow Jones, and Nasdaq 100 indices were trading higher.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46108861/microsoft-is-playing-chess-and-others-are-playing-checkers-dan-ives-says-msft-could-be-a-5-trill">Microsoft Is &#8216;Playing Chess, And Others Are Playing Checkers:&#8217; Dan Ives Says MSFT Could Be A $5 Trillion Company In 18 Months</a></li>
</ul>
Photo courtesy: Jack Hong / Shutterstock.com

AAPL

AVGO

MSFT

NVDA

Billionaire David Tepper Dumps Nvidia, Slashes 'Magnificent 7' Holdings — But Bets Big On These 2 AI And Blockchain Plays

House Republicans want to let Americans swipe their Health Savings Account cards at the front desk of their local gym, but the Senate isn't sweating the idea yet.
What Happened: Under the <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45564489/trumps-big-tax-bill-clears-the-house-30-year-yields-jump-to-515-as-bond-market-freaks">House-passed</a> "One Big Beautiful Bill Act," up to $500 a year, $1,000 for couples, spent on memberships or fitness classes such as weight training, swimming, or spin would qualify as a medical expense, making those dollars tax-free.
Currently, HSA holders typically require a doctor's letter stating they have obesity, heart disease, or another qualifying condition before their plan will reimburse a gym fee. The House provision would scrap that paperwork, a change the fitness industry says would drive longer contracts and more personal-training packages, according to a recent <a href="https://www.washingtonpost.com/business/2025/06/25/hsa-gym-membership-wellness/">report</a> by The Washington Post.
The non-partisan Joint Committee on Taxation pegs the 2026-34 revenue hit at $10.5 billion.
See also: <a href="https://www.benzinga.com/news/politics/25/06/46108200/trump-calls-for-canceling-netanyahus-witch-hunt-corruption-trial-calls-it-a-travesty-of-justice">Trump Calls For Canceling Netanyahu&#8217;s &#8216;Witch-Hunt&#8217; Corruption Trial, Calls It A &#8216;Travesty Of Justice&#8217;</a>
Why It Matters: But the Senate Finance Committee has since stripped every HSA expansion — including the gym benefit — from their draft, forcing lobbyists to mount a late-game push before a floor vote expected as early as next week. Any final measure must reconcile the two versions before Republicans' self-imposed July 4 deadline to reach President Donald Trump's desk.
Fitness chains see money on the line. Jennifer Garrett, senior director at 24 Hour Fitness, told The Washington Post that members who use HSAs tend to pay for a year in advance, or &#8220;purchase personal training," boosting revenue for the California-based company. Industry allies range from the National Football League to local YMCAs, which already partner with services like TrueMed to secure doctor letters for clients.
Consumer advocates call the change preventive care, but fiscal hawks call it a niche perk that <a href="https://www.benzinga.com/news/health-care/25/05/45692784/20-million-more-americans-could-gain-hsa-access-under-trumps-big-beautiful-bill-but-it-wont-be-cheap">widens a tax break</a> used mostly by higher-income households. If the House language survives, the nation's 39 million <a href="https://www.benzinga.com/money/benefits-of-a-health-savings-account">HSA account holders</a> who stashed $55 billion tax-free last year could soon get a built-in discount on their New Year's resolution.
Read next: <a href="https://www.benzinga.com/news/politics/25/06/46109077/eric-trump-shelves-plan-to-bring-trump-branded-property-in-israels-tel-aviv-amid-ongoing-regional-tensions-report">Eric Trump Shelves Plan To Bring Trump-Branded Property In Israel&#8217;s Tel Aviv Amid Ongoing Regional Tensions: Report</a>
Image via Shutterstock

Tax Free Gym Visits And Swimming Lessons For Americans? House-Approved HSA Expansion Could Make It Happen, But Senate Isn't That Keen

Prenetics Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRE#NASDAQ">PRE</a>), a leading consumer health sciences company, announced today at a special event at Wimbledon House that IM8, its premium supplements brand co-founded by David Beckham, has partnered with world No. 1 tennis star Aryna Sabalenka as its newest global ambassador and shareholder. The announcement comes just days before the start of Wimbledon on June 30th, where Sabalenka will be competing as one of the tournament favorites.
 &nbsp;
The partnership marks a significant milestone for both Sabalenka and IM8, as this represents the first time the tennis champion has endorsed a supplement brand. The collaboration was born organically after Sabalenka experienced remarkable benefits from using IM8's Daily Ultimate Essentials, which is NSF Certified for Sport&#xAE;, since the beginning of 2025.
Sabalenka, who is preparing for Wimbledon after an impressive first half of 2025 that saw her claim three prestigious titles in Brisbane, Miami, and Madrid, has reported significant improvements in energy, endurance, digestion, and cognitive focus since incorporating IM8 into her daily routine. Her entire team, including her tennis coaches and personal trainer, have also become regular users of the product.

Prenetics Global Teams Up with Aryna Sabalenka as IM8 Brand Ambassador and Shareholder

<h3>Companies Reporting Before The Bell</h3>
• HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) is projected to report quarterly loss at $0.11 per share on revenue of $31.47 million. 
• Orion Energy Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OESX#NASDAQ">OESX</a>) is projected to report quarterly loss at $0.03 per share on revenue of $21.08 million. 
• Lindsay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNN#NYSE">LNN</a>) is expected to report quarterly earnings at $1.40 per share on revenue of $157.90 million. 
• Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is projected to report quarterly earnings at $0.34 per share on revenue of $36.72 billion. 
• McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is estimated to report quarterly earnings at $0.66 per share on revenue of $1.66 billion. 
• Acuity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) is estimated to report quarterly earnings at $4.49 per share on revenue of $1.16 billion. 
<h3>Companies Reporting After The Bell</h3>
• Origin Agritech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEED#NASDAQ">SEED</a>) is likely to report earnings for its first quarter. 
• Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) is estimated to report earnings for its fourth quarter. 
• Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $10.70 billion. 
• American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) is projected to report quarterly loss at $0.11 per share on revenue of $48.46 million. 
• Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $2.75 per share on revenue of $2.38 billion. 
• Enerpac Tool Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAC#NYSE">EPAC</a>) is projected to report quarterly earnings at $0.47 per share on revenue of $162.20 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

AEMD

AOUT

CNXC

EPAC

HIVE

OESX

SEED

Earnings Scheduled For June 26, 2025

Nvidia Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO&nbsp;Jensen Huang&nbsp;has revealed that the company&#8217;s next major growth opportunity lies in robotics, aside from artificial intelligence (AI).
What Happened:&nbsp;At Nvidia&#8217;s annual shareholders meeting on Wednesday, Huang identified robotics as the company&#8217;s second-largest market for potential growth, following AI,&nbsp;<a href="https://www.cnbc.com/2025/06/25/nvidia-shareholder-meeting-2025-robots.html">reported</a>&nbsp;CNBC.
"We have many growth opportunities across our company, with AI and robotics the two largest, representing a multitrillion-dollar growth opportunity,"&nbsp;stated Huang. 
He stated that the first significant commercial application for this technology would be self-driving cars. Despite its current relatively small size, the robotics division has seen a 72% annual increase, with&nbsp;$567 million in quarterly sales,&nbsp;accounting for nearly 1% of the&nbsp;company&#8217;s total revenue.
While Nvidia&#8217;s sales have surged thanks to strong demand for its data center GPUs, Huang expects the robotics sector to drive further growth—requiring the company's AI chips for software training, along with additional chips used in autonomous vehicles and robots. Huang said Nvidia is shifting its identity toward being an "AI infrastructure" or "computing platform" provider. "We stopped thinking of ourselves as a chip company long ago," Huang says.
Huang pointed to Nvidia's Drive platform—its suite of chips and software for autonomous vehicles—currently in use by Mercedes-Benz. The company has also recently launched AI models for humanoid robots, known as Cosmos.
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/46107638/mark-zuckerbergs-meta-beats-lawsuit-over-ai-training-on-books-judge-finds-no-meaningful-evidence-on-market-dilution" target="_blank" rel="noreferrer noopener">Mark Zuckerberg's Meta Beats Lawsuit Over AI Training On Books, Judge Finds ‘No Meaningful Evidence On Market Dilution'</a>
Why It Matters: Nvidia&#8217;s stock has been performing exceptionally well, reaching a record high on Wednesday, with the company&#8217;s market cap now standing at approximately $3.75 trillion. This makes Nvidia&nbsp;the most valuable company in&nbsp;the world, ahead of&nbsp;Microsoft&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
This announcement comes on the heels of Nvidia&#8217;s recent rebound from a 17% drop in January, which was initially sparked by fears that China&#8217;s DeepSeek AI could challenge Nvidia&#8217;s <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46098276/nvidia-stock-soars-near-record-high-whats-driving-the-rally">market dominance</a>. The stock&#8217;s recovery has been fueled by a significant easing in U.S.-China trade tensions and a stellar first-quarter earnings report on May 28.
Moreover, despite generating almost <a href="https://www.benzinga.com/markets/tech/25/06/46058862/nvidia-intel-chip-stocks-ai-valuation-revenue">four times</a> as much revenue as&nbsp;Intel&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) on an annualized basis, Nvidia trades at less than half of Intel&#8217;s forward price-to-earnings ratio. 
According to Benzinga Edge Stock Rankings, Nvidia has a growth score of 98.65% and a momentum rating of 70.43%. Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here </a>to see how it compares to other leading tech companies.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://www.benzinga.com/markets/25/06/46009990/nvidia-stock-could-rise-another-38-making-jensen-huang-led-ai-giant-a-nearly-5-trillion-company-says">Nvidia Stock Could Rise Another 38%, Making Jensen Huang-Led AI Giant A Nearly $5 Trillion Company, Says Barclays</a> </li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

INTC

Nvidia's Next 'Multitrillion Dollar' Opportunity? Jensen Huang Sees Great Potential Here: 'Stopped Thinking Of Ourselves As A Chip Company Long Ago'

Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>, ALVO SDB, the "Company"))), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders under the Company's existing senior secured term loan facility, including GoldenTree Asset Management (collectively, the "Lenders"), have agreed to reduce the rate of interest on its existing senior secured term loan facility (the "Facility"). The agreement will lower Alvotech's interest payments in the first 12 months by an estimated US$8.2 million. This is an outcome of Alvotech's sustained operational improvements and strengthened financial performance over the past year.
"Since last year, we have shown significant revenue growth, operating profits and positive adjusted EBITDA, and we expect to be able to fund future growth based on milestone and product revenue. Being able to reduce our cost of capital demonstrates great confidence, by a group of experienced healthcare investors, in Alvotech's leadership, our pipeline progress and prospects for near-term product launches." said Joel Morales, Chief Financial Officer of Alvotech.
The Facility was funded in July 2024 and matures in July 2029. It originally consisted of two tranches: a $900 million first-out term loan tranche (the "first tranche"), with an interest rate of SOFR plus 6.5% per annum, and a $65 million second-out term loan tranche (the "second tranche"), with an interest rate of SOFR plus 10.5% per annum. In conjunction with this transaction, certain of the Lenders have agreed to increase the first tranche to include the second tranche, creating one single tranche going forward, further simplifying Alvotech's capital structure. The interest rate for this Facility will be SOFR plus 6.0% per annum, and all interest will be payable in cash. Following this transaction, the balance of the Facility is approximately $1,081 million and the Company's cash balance was approximately $152 million, as of June 25, 2025.

ALVO

Alvotech Secures Interest Rate Reduction on $1.1B Loan, Saving $8.2M in First-Year Payments

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iff.com&amp;esheet=54282247&amp;newsitemid=20250626427440&amp;lan=en-US&amp;anchor=IFF&amp;index=1&amp;md5=0db764702d605eb4aee3402b59c01b45">IFF</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>)—a global leader in flavors, fragrances, food ingredients, health, and biosciences—announced the launch of <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iff.com%2Ffood-beverage%2Ffood-bioscience%2Fcultures%2Fdairy-cultures%2Fchoozit-lift-lets-craft-the-future%2F&amp;esheet=54282247&amp;newsitemid=20250626427440&amp;lan=en-US&amp;anchor=CHOOZIT%26%23174%3B+LIFT&amp;index=2&amp;md5=76814795ef0868b75a090f6fea84f829">CHOOZIT&#xAE; LIFT</a>, a first-of-its-kind <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fbioscience.iff.com%2Fsolutions%2Ffood-and-beverages%2Fdairy%2Fcheese-cultures&amp;esheet=54282247&amp;newsitemid=20250626427440&amp;lan=en-US&amp;anchor=culture&amp;index=3&amp;md5=f7f5bcdb6a16df9b090c5cc564ef4e61">culture</a> developed to transform the production of semi-hard cheeses for significant <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iff.com%2Fsustainability%2F&amp;esheet=54282247&amp;newsitemid=20250626427440&amp;lan=en-US&amp;anchor=sustainability&amp;index=4&amp;md5=eff55df0ef84eccc37a3ce7e30a16c20">sustainability</a> and business benefits. Leveraging the company's extensive <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iff.com%2Fscience%2Finnovations%2F&amp;esheet=54282247&amp;newsitemid=20250626427440&amp;lan=en-US&amp;anchor=bioscience&amp;index=5&amp;md5=d3fd796ea43b1065ef4e067ed6a17a7d">bioscience</a> expertise, the solution combines advanced strain design with practical <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iff.com%2Ffood-beverage%2Fdairy%2F&amp;esheet=54282247&amp;newsitemid=20250626427440&amp;lan=en-US&amp;anchor=cheesemaking&amp;index=6&amp;md5=a06d521350046cc3a65883f2cc62596d">cheesemaking</a> knowledge to eliminate the curd washing step from the process entirely. In doing so, this novel culture helps reduce water and energy use in production while maintaining the high quality of the final products to meet consumer expectations.

IFF's New CHOOZIT LIFT Culture Cuts Water and Energy Use in Cheese Making While Maintaining Quality

Apollo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) today announced that funds managed by its affiliates (the "Apollo Funds") have agreed to sell their interest in MAFTEC Group Co., Ltd. ("MAFTEC" or the "Company"), a Japan based global leader in ultra-high temperature heat insulating solutions serving the automotive and industrial end-markets, to funds managed by Advantage Partners.
MAFTEC was formed through the separation of Mitsubishi Chemical's Thermal and Emission Control Materials business, which was acquired by the Apollo Funds in March 2022. As a strategic partner, the Apollo team played a pivotal role in supporting the design and launch of the MAFTEC&#x2122;&nbsp;product suite, which helped to form the Company's foundation in the marketplace and drove significant EBITDA expansion over the past three years.

Asset Sales

Apollo to Sell Stake in MAFTEC, a Leader in Heat Insulating Solutions for Automotive and Industrial Markets

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) CEO Satya Nadella called Palantir Technologies Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) Forward Deployed Engineer model &#8220;fantastic&#8221; at a Y Combinator event, prompting industry debate about the data analytics company&#8217;s unique approach to product development.
What Happened: Chad Wahlquist, Forward Deployed Architect at Palantir, responded to Nadella&#8217;s comments on X, rejecting misconceptions about the FDE model. &#8220;Many mistakenly believe the FDE model is just a new name for a change management consulting model. False,&#8221; Wahlquist wrote.
The FDE approach places engineers directly with customers to build products at the point of need rather than relying on traditional consulting methodologies. 
&#8220;FDEs build the product customers need, when they need it, at the edge,&#8221; Wahlquist explained. &#8220;The feedback loop from FDEs experiencing customer pain at the edge and turning it into product allows us to cycle and build the right product much faster.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Many mistakenly believe the FDE model is just a new name for a change management consulting model. False. FDEs build the product customers need, when they need it, at the edge. The feedback loop from FDEs experiencing customer pain at the edge and turning it into product allows… <a href="https://t.co/n5Z4d9W14P">https://t.co/n5Z4d9W14P</a>
&mdash; Chad Wahlquist (@chadwahl) <a href="https://twitter.com/chadwahl/status/1937994139280551978?ref_src=twsrc%5Etfw">June 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This methodology differs significantly from traditional enterprise software sales cycles. Where companies like Salesforce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) and Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) rely on lengthy relationship-building processes, Palantir embeds technical experts directly with <a href="https://www.benzinga.com/markets/equities/25/06/45738764/garry-tan-says-founders-must-build-with-customers-to-compete-with-giants-like-salesforce-oracle-you-cant-farm-this-out">clients using its Foundry platform</a>.
Y Combinator CEO Garry Tan, who worked at Palantir from 2005 to 2007, previously outlined how FDEs sit with clients like FBI agents <a href="https://www.benzinga.com/markets/equities/25/06/45738764/garry-tan-says-founders-must-build-with-customers-to-compete-with-giants-like-salesforce-oracle-you-cant-farm-this-out">investigating domestic terrorism</a>, observing actual workflows. &#8220;Instead of the next meeting being reviewing 50 pages of sales documentation, it&#8217;s literally like &#8216;Okay we built it,'&#8221; Tan said on the Lightcone Podcast.
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/46107638/mark-zuckerbergs-meta-beats-lawsuit-over-ai-training-on-books-judge-finds-no-meaningful-evidence-on-market-dilution">Mark Zuckerberg&#8217;s Meta Beats Lawsuit Over AI Training On Books, Judge Finds &#8216;No Meaningful Evidence On Market Dilution&#8217;</a>
Why It Matters: The model&#8217;s effectiveness has attracted attention from major financial institutions. JPMorgan Chase &amp; Co. CEO Jamie Dimon recalled his 2012 encounter with Palantir: &#8220;I remember sitting down with the Palantir people and going through this AI thing saying holy Christ this is this is unbelievable.&#8221; 
JPMorgan subsequently established its own AI department and <a href="https://www.benzinga.com/markets/tech/25/06/45897537/jamie-dimon-recalls-first-palantir-meeting-holy-christ-this-is-unbelievable-jpmorgan-now-has-600-ai-use-cases-2-billion-annual-investment-on-ai">now invests $2 billion annually in artificial intelligence</a> across 600 active use cases.
Palantir shares have surged over 492% in the past 12 months, reaching new all-time highs near $143. The company recently raised 2025 revenue guidance to $3.89-3.90 billion while projecting adjusted free <a href="https://www.benzinga.com/markets/equities/25/06/45738764/garry-tan-says-founders-must-build-with-customers-to-compete-with-giants-like-salesforce-oracle-you-cant-farm-this-out">cash flow between $1.6-1.8 billion</a>. Recent catalysts include a $795 million Defense Department contract and commercial partnerships.
According to&nbsp;Benzinga&#8217;s Edge Stock Rankings, Palantir shows strong Short-, Medium-, and Long-Term Price Trends. Here&#8217;s&nbsp;<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">how the stock performs across other key metrics</a>.
<figure class="wp-block-image aligncenter size-full is-resized"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26032154/Screenshot-2025-06-26-at-12.50.39%E2%80%AFPM.png" alt="" class="wp-image-962683" style="width:434px;height:auto" /></a></figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46106134/bernie-sanders-shares-first-thing-he-would-do-as-president-and-it-could-be-a-jab-at-elon-musk" target="_blank" rel="noreferrer noopener">Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: slyellow / Shutterstock.com

ORCL

PLTR

Microsoft CEO Satya Nadella Praises Palantir's FDE Model As 'Fantastic'—Insiders Say It's Not Consulting, It Builds 'The Product Customers Need'

Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts and former federal officials after its first meeting strayed sharply from established scientific review norms.
What Happened: On Wednesday, the Advisory Committee on Immunization Practices reconvened under controversy, just weeks after Kennedy dismissed all 17 previous members of the committee and replaced them with his appointees, according to Reuters.
Criticism has since intensified after the panel&#8217;s agenda was abruptly changed only one day before the meeting, while adding a presentation on thimerosal, a vaccine preservative whose alleged risks have been repeatedly debunked by mainstream science. 
The presentation was delivered by Lyn Redwood, former leader of Children&#8217;s Health Defense, an anti-vaccine organization originally founded by Kennedy himself.
The reconstituted panel is already seeing a fallout, with Dr. Michael Ross, one of the newly appointed members, resigning unexpectedly before the first meeting was held. Two other Centers for Disease Control and Prevention staff members also left amid the chaos.
At least half of Kennedy&#8217;s appointees have publicly questioned vaccine safety in the past, leading organizations such as the American Academy of Pediatrics, a non-voting participant of these meetings, to skip, citing a lack of scientific credibility and procedural transparency. The organization plans to publish its evidence-based childhood vaccine schedules instead.
The panel&#8217;s chair, Dr. Martin Kulldorff, stated that the committee would review individual vaccines, as well as the cumulative effects and scheduling of childhood immunizations.
The committee also postponed a key vote on an RSV vaccine intended for children, further heightening uncertainty around upcoming vaccine recommendations.
Why It Matters: The overhaul of the CDC's vaccine schedules stands to have a significant impact on pharma companies, especially those with exposure to childhood vaccines. 
For instance, Pfizer Inc. and Moderna Inc., with their Respiratory Syncytial Virus (RSV) vaccines, stand to see some headwinds due to the committee postponing its vote on the vaccine.
Similarly, Merck &amp; Co. Inc., having reported $540 million in revenue during its <a href="https://www.benzinga.com/general/biotech/25/04/44983460/mercks-q1-earnings-beat-wall-street-adjusts-2025-profit-outlook-as-tariffs-may-result-in-incremental-cost-of-200-million">first quarter results</a> from its <a href="https://www.benzinga.com/trading-ideas/long-ideas/19/04/13514693/nyc-mandates-measles-vaccinations-merck-is-the-exclusive-manufacturer">measles-mumps-rubella (MMR) vaccine</a> series, could see a material impact as a result of the vaccine advisory committee&#8217;s stance.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>Potential Impact</th>
<th class="has-text-align-center" data-align="center">YTD Performance</th>
</tr>
</thead>
<tbody>
<tr>
<td>Merck &amp; Co Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>)</td>
<td>Outsized exposure to childhood vaccination schedules, with its MMR series.</td>
<td class="has-text-align-center" data-align="center">-19.66%</td>
</tr>
<tr>
<td>Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)</td>
<td>Delays in the approval of its RSV vaccines</td>
<td class="has-text-align-center" data-align="center">-8.83%</td>
</tr>
<tr>
<td>Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>)</td>
<td>RSV vaccine delays, along with the dropped COVID-19 vaccine mandate for pregnant women.</td>
<td class="has-text-align-center" data-align="center">-36.05%</td>
</tr>
</tbody>
</table>
</figure>
Price Action: Merck shares were down 0.81% on Wednesday, trading at $79.67, with the stock trading up 0.04% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="147" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26030246/Screenshot-2025-06-26-at-12.32.31-PM-1024x147.png" alt="" class="wp-image-962643" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26030246/Screenshot-2025-06-26-at-12.32.31-PM-1024x147.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26030246/Screenshot-2025-06-26-at-12.32.31-PM-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26030246/Screenshot-2025-06-26-at-12.32.31-PM-768x110.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26030246/Screenshot-2025-06-26-at-12.32.31-PM.png 1536w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Merck scores well on Growth in Benzinga&#8217;s Edge Stock Rankings, with a favorable price trend in the short term. How does it compare with Pfizer and Moderna? Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> to find out.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46106134/bernie-sanders-shares-first-thing-he-would-do-as-president-and-it-could-be-a-jab-at-elon-musk" target="_blank" rel="noreferrer noopener">Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk</a></li>
</ul>
Photo courtesy: lev radin / Shutterstock.com

Politics

MRNA

RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group

Warren Buffett&#8216;s Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) is reportedly no longer enjoying the &#8220;Buffett premium&#8221; that once made its stock a hot commodity, according to analysts.
What Happened: Investors have historically been willing to pay a premium for Berkshire Hathaway&#8217;s stock due to Buffett&#8217;s credibility and history of successful investments. However, this premium is now in question, <a href="https://www.marketwatch.com/story/the-vanishing-buffett-premium-has-berkshire-hathaway-lost-the-oracle-of-omahas-aura-38cd10ed">MarketWatch</a> reported.
Though not precisely measurable, the &#8220;Buffett premium&#8221; is often assessed by comparing the stock's market value to its intrinsic value or price-to-book ratio.
Investors seem to be growing reluctant to pay a premium for Berkshire's stock, with Class B shares trading at 1.5 times book value as of Monday close—down from a recent high of about 1.7 times on May 2, the last trading day before the company's annual shareholder meeting, as per MarketWatch data. 
Since Buffett revealed his intention to step down as CEO by year-end and hand over the reins to Greg Abel, Berkshire's Class B shares have fallen nearly 5%. In contrast, the S&amp;P 500 has risen nearly 3% during the same timeframe.
Wellington-Altus Private Wealth&#8216;s Chief Market Strategist, Jim Thorn, commented, &#8220;It&#8217;s completely natural that the premium would be reduced until the market really gets a full handle on what Berkshire Hathaway looks like in this new environment, with Greg Abel solely at the helm.&#8221;
Thorn also reasoned that Buffett&#8217;s retirement announcement may not be the only reason. The market is growing &#8216;more comfortable&#8217; in President Donald Trump&#8216;s economic policies, viewing them as potentially less inflationary and possibly even addressing the deficit. 
Greggory Warren, a senior stock analyst at Morningstar, told MarketWatch that Buffett had the &#8220;luxury&#8221; from shareholders largely ignoring the numbers and not paying close attention to how Berkshire's returns have actually performed over the past 10 to 15 years.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/politics/25/06/46094069/iran-breaks-silence-says-nuclear-facilities-badly-damaged-by-us-strikes" target="_blank" rel="noreferrer noopener">Iran Breaks Silence, Says Nuclear Facilities &#8216;Badly Damaged&#8217; By US Strikes</a>
Why It Matters: The &#8220;Buffett premium&#8221; has been a significant factor in Berkshire Hathaway&#8217;s stock valuation for many years. However, with the impending change in leadership and shifts in market psychology, investors are re-evaluating the stock&#8217;s worth.
Buffett&#8217;s departure as CEO, announced in May, has been linked to the <a href="https://www.benzinga.com/news/management/25/05/45199066/berkshire-hathaway-stock-falls-following-buffetts-retirement-as-ceo">stock&#8217;s decline</a>. However, the company&#8217;s new CEO, Abel, has assured that the company&#8217;s investment philosophy will remain unchanged.
Despite the recent underperformance, Berkshire Hathaway has a solid balance sheet and a diversified portfolio, making&nbsp;it less sensitive to economic&nbsp;cycles and higher interest rates.&nbsp;The company&#8217;s future performance under Abel&#8217;s leadership, as well as the potential for changes in the company&#8217;s financial strategy, will be closely watched by investors.
Buffett&#8217;s investment approach, which focuses&nbsp;on corporate fundamentals, cash flow,&nbsp;and the intrinsic value of&nbsp;a company, has been&nbsp;<a href="https://www.benzinga.com/general/education/25/05/45684308/warren-buffett-net-worth-soars-in-2025-oracle-of-omaha-worth-as-much-as-jensen-huang-phil-knight-mark-cuban-combined">questioned in today&#8217;s market</a>, which favors growth stocks. Abel&#8217;s approach and potential changes to the company&#8217;s financial strategy will be crucial in determining the stock&#8217;s future performance.
On a year-to-date basis, the Berkshire Hathaway Class B shares climbed 7.78%, outperforming the S&amp;P 500&#8217;s 3.8% gain during the same period. 
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/politics/25/06/46107353/trump-says-democrats-have-crossed-the-line-with-zohran-mamdani-bernie-sanders-elizabeth-warren-back" target="_blank" rel="noreferrer noopener">Trump Says Democrats Have &#8216;Crossed The Line&#8217; With Zohran Mamdani — Bernie Sanders, Elizabeth Warren Back New York Mayoral Candidate&#8217;s &#8216;Grassroots&#8217; Support</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

'Buffett Premium' Fading Away? The Oracle Of Omaha's Retirement Casts Shadow On Berkshire Hathaway's Stock Value: Report

Press Releases

MarketWise Inc. Reports Preliminary Selected Unaudited Fourth Quarter 2024 Billings of $55 Million, over a 10% Increase from Prior Quarter; Announces Special Dividend of $0.03 Per Share

MarketWise to present at the UBS Financial Services Forum on February 11, 2025

MarketWise Reports Net Income of $93.1 Million and Net Revenue of $408.7 Million for Full Year 2024, and Announces Stock Repurchase Program of up to $50 Million

Dividends

MarketWise Declares Dividend on Common Stock

MarketWise Announces 1-for-20 Reverse Stock Split

MarketWise Inc. Reports Preliminary Selected Unaudited First Quarter Billings of $70 Million, Over a 26% Increase from Prior Quarter; Commences Share Buyback Program; LTM Cash Dividend Yield Totals 16%

MarketWise Declares Quarterly Dividend of $0.20 Per Share on Common Stock; Announces Special Dividend of $0.10 Per Share

MarketWise to Present at the UBS SMID-Cap Multisector Virtual Conference on June 24, 2025

MarketWise Reports Net Revenue of $83.5 Million for First Quarter 2025 and Net Income of $16.8 Million; First Quarter Billings Increase 27% from Prior Quarter; Cash From Operating Activities Improves by $20.2 Million; Provides FY 2025 Financial Targets; Announced Quarterly and Special Dividend Totaling $0.30 per Class A Share

Comments

Marketwise

Marketwise (MKTW) Opciones

Marketwise (NASDAQ:MKTW) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL